Read More Pharma Industry News Breakthrough for Wilson disease: Innorna’s IN013 wins dual FDA fast-track approvals Innorna accelerates mRNA treatment for Wilson Disease with dual FDA designations. Discover how IN013 could transform care for rare genetic disorders! byPallavi MadhirajuApril 27, 2025